527 related articles for article (PubMed ID: 16209039)
21. The role of the PAX8/PPARgamma fusion oncogene in the pathogenesis of follicular thyroid cancer.
Eberhardt NL; Grebe SK; McIver B; Reddi HV
Mol Cell Endocrinol; 2010 May; 321(1):50-6. PubMed ID: 19883731
[TBL] [Abstract][Full Text] [Related]
22. Cytogenetic and molecular events in adenoma and well-differentiated thyroid follicular-cell neoplasia.
Caria P; Vanni R
Cancer Genet Cytogenet; 2010 Nov; 203(1):21-9. PubMed ID: 20951315
[TBL] [Abstract][Full Text] [Related]
23. Identification of a paired box gene 8-peroxisome proliferator-activated receptor gamma (PAX8-PPARgamma) rearrangement mosaicism in a patient with an autonomous functioning follicular thyroid carcinoma bearing an activating mutation in the TSH receptor.
Lado-Abeal J; Celestino R; Bravo SB; Garcia-Rendueles ME; de la Calzada J; Castro I; Castro P; Espadinha C; Palos F; Soares P; Alvarez CV; Sobrinho-Simões M; Cameselle-Teijeiro J
Endocr Relat Cancer; 2010 Sep; 17(3):599-610. PubMed ID: 20427420
[TBL] [Abstract][Full Text] [Related]
24. The oncogenic activity of RET point mutants for follicular thyroid cells may account for the occurrence of papillary thyroid carcinoma in patients affected by familial medullary thyroid carcinoma.
Melillo RM; Cirafici AM; De Falco V; Bellantoni M; Chiappetta G; Fusco A; Carlomagno F; Picascia A; Tramontano D; Tallini G; Santoro M
Am J Pathol; 2004 Aug; 165(2):511-21. PubMed ID: 15277225
[TBL] [Abstract][Full Text] [Related]
25. Treatment directed to signalling molecules in patients with advanced differentiated thyroid cancer.
Sáez JM
Anticancer Agents Med Chem; 2013 Mar; 13(3):483-95. PubMed ID: 22583421
[TBL] [Abstract][Full Text] [Related]
26. Survey of 548 oncogenic fusion transcripts in thyroid tumors supports the importance of the already established thyroid fusions genes.
Celestino R; Sigstad E; Løvf M; Thomassen GO; Grøholt KK; Jørgensen LH; Berner A; Castro P; Lothe RA; Bjøro T; Sobrinho-Simões M; Soares P; Skotheim RI
Genes Chromosomes Cancer; 2012 Dec; 51(12):1154-64. PubMed ID: 22961909
[TBL] [Abstract][Full Text] [Related]
27. Follicular thyroid tumors with the PAX8-PPARgamma1 rearrangement display characteristic genetic alterations.
Lacroix L; Lazar V; Michiels S; Ripoche H; Dessen P; Talbot M; Caillou B; Levillain JP; Schlumberger M; Bidart JM
Am J Pathol; 2005 Jul; 167(1):223-31. PubMed ID: 15972966
[TBL] [Abstract][Full Text] [Related]
28. [Advances in studies of the genes related to thyroid carcinoma].
Zhi JT; Zheng XQ; Gao M
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Dec; 51(12):951-955. PubMed ID: 27978891
[TBL] [Abstract][Full Text] [Related]
29. Activation of the RAS/RAF/ERK signaling pathway contributes to resistance to sunitinib in thyroid carcinoma cell lines.
Piscazzi A; Costantino E; Maddalena F; Natalicchio MI; Gerardi AM; Antonetti R; Cignarelli M; Landriscina M
J Clin Endocrinol Metab; 2012 Jun; 97(6):E898-906. PubMed ID: 22442268
[TBL] [Abstract][Full Text] [Related]
30. Underexpression of peroxisome proliferator-activated receptor (PPAR)gamma in PAX8/PPARgamma-negative thyroid tumours.
Marques AR; Espadinha C; Frias MJ; Roque L; Catarino AL; Sobrinho LG; Leite V
Br J Cancer; 2004 Aug; 91(4):732-8. PubMed ID: 15238980
[TBL] [Abstract][Full Text] [Related]
31. Molecular pathology of thyroid tumours of follicular cells: a review of genetic alterations and their clinicopathological relevance.
Acquaviva G; Visani M; Repaci A; Rhoden KJ; de Biase D; Pession A; Giovanni T
Histopathology; 2018 Jan; 72(1):6-31. PubMed ID: 29239040
[TBL] [Abstract][Full Text] [Related]
32. Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features Accounts for More Than Half of "Carcinomas" Harboring RAS Mutations.
Paulson VA; Shivdasani P; Angell TE; Cibas ES; Krane JF; Lindeman NI; Alexander EK; Barletta JA
Thyroid; 2017 Apr; 27(4):506-511. PubMed ID: 28114855
[TBL] [Abstract][Full Text] [Related]
33. A subset of the follicular variant of papillary thyroid carcinoma harbors the PAX8-PPARgamma translocation.
Castro P; Roque L; Magalhães J; Sobrinho-Simões M
Int J Surg Pathol; 2005 Jul; 13(3):235-8. PubMed ID: 16086077
[TBL] [Abstract][Full Text] [Related]
34. RET receptor expression in thyroid follicular epithelial cell-derived tumors.
Bunone G; Uggeri M; Mondellini P; Pierotti MA; Bongarzone I
Cancer Res; 2000 Jun; 60(11):2845-9. PubMed ID: 10850426
[TBL] [Abstract][Full Text] [Related]
35. Molecular genetics of childhood papillary thyroid carcinomas after irradiation: high prevalence of RET rearrangement.
Rabes HM; Klugbauer S
Recent Results Cancer Res; 1998; 154():248-64. PubMed ID: 10027005
[TBL] [Abstract][Full Text] [Related]
36. RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma.
Nikiforova MN; Lynch RA; Biddinger PW; Alexander EK; Dorn GW; Tallini G; Kroll TG; Nikiforov YE
J Clin Endocrinol Metab; 2003 May; 88(5):2318-26. PubMed ID: 12727991
[TBL] [Abstract][Full Text] [Related]
37. Pioglitazone induces a proadipogenic antitumor response in mice with PAX8-PPARgamma fusion protein thyroid carcinoma.
Dobson ME; Diallo-Krou E; Grachtchouk V; Yu J; Colby LA; Wilkinson JE; Giordano TJ; Koenig RJ
Endocrinology; 2011 Nov; 152(11):4455-65. PubMed ID: 21952241
[TBL] [Abstract][Full Text] [Related]
38. Molecular genetic study comparing follicular variant versus classic papillary thyroid carcinomas: association of N-ras mutation in codon 61 with follicular variant.
Di Cristofaro J; Marcy M; Vasko V; Sebag F; Fakhry N; Wynford-Thomas D; De Micco C
Hum Pathol; 2006 Jul; 37(7):824-30. PubMed ID: 16784981
[TBL] [Abstract][Full Text] [Related]
39. High prevalence of BRAF gene mutation in papillary thyroid carcinomas and thyroid tumor cell lines.
Xu X; Quiros RM; Gattuso P; Ain KB; Prinz RA
Cancer Res; 2003 Aug; 63(15):4561-7. PubMed ID: 12907632
[TBL] [Abstract][Full Text] [Related]
40. Low frequency of PAX8-PPARγ rearrangement in follicular thyroid carcinomas in Japanese patients.
Mochizuki K; Kondo T; Oishi N; Tahara I; Inoue T; Kasai K; Nakazawa T; Okamoto T; Shibata N; Katoh R
Pathol Int; 2015 May; 65(5):250-3. PubMed ID: 25708358
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
